Rashi Peripherals to sell 26% of Rashi Semiconductor Solutions to Restar, seeks ₹900 crore
- Agreement
- Computer peripherals and distribution
Rashi Peripherals (NSE: RPTECH) approved a secondary sale of 26% of its wholly owned subsidiary Rashi Semiconductor Solutions Private Limited to Restar Corporation, Japan, and an equity fund-raise of up to ₹900 crore, it said in a filing on 05 Nov 2026. Shareholder approval is needed for the fund-raise and the capital increase.
Key highlights
- Stake to be sold: 26% of Rashi Semiconductor Solutions Private Limited
- Fund-raise ceiling: ₹900 crore through equity issuance
- Authorised share capital: ₹35 crore rising to ₹50 crore
- Lock-in period under the proposed agreement: five years
The approvals in numbers
| Item | Detail |
|---|---|
| Counterparty | Restar Corporation, Japan |
| Stake sold | 26% of Rashi Semiconductor Solutions Private Limited (RSSPL), a wholly owned subsidiary |
| Deal type | Secondary sale of shares |
| Lock-in period | Five years, with transfer restrictions |
| Fund-raise ceiling | ₹900 crore through QIP, preferential issue or other permissible modes |
| Authorised share capital | ₹35 crore (7,00,00,000 shares) to ₹50 crore (10,00,00,000 shares of ₹5 each) |
| Statutory auditor appointed | Price Waterhouse Chartered Accountants LLP, from 05 Nov 2026 to the ensuing AGM |
The stake sale and the proposed agreement
The board approved the execution of a Share Purchase Agreement and Shareholders Agreement with Restar Corporation, Japan, for the secondary sale of 26% of RSSPL. The company describes the sale as a strategic sale of a stake in its wholly owned subsidiary by way of a secondary sale.
Under the proposed agreement, RSSPL's board would have three directors nominated by Rashi Peripherals (Chairman, Managing Director and Whole-time Director) and one nominated by Restar (Vice Chairman). The agreement includes a five-year lock-in with transfer restrictions and a non-compete for both parties. The company says execution is subject to applicable statutory, regulatory and contractual approvals where required.
Capital, fund-raise and auditor changes
The board proposed raising its authorised share capital from ₹35 crore to ₹50 crore, an increase of ₹15 crore, by creating 3,00,00,000 additional equity shares of ₹5 each. It also approved raising up to ₹900 crore through equity issuance, subject to shareholder approval. The filing does not give a timetable for either step.
The board also appointed Price Waterhouse Chartered Accountants LLP as joint statutory auditors to fill the casual vacancy left when Deloitte Haskins and Sells LLP became ineligible under Section 141(3)(e) of the Companies Act, 2013. Sanjeev Keskar was appointed an additional independent director, subject to shareholder approval, and the board committees were reconstituted from 6 Nov 2026.
What the Restar agreement and fund-raise mean for Rashi Peripherals' shareholders
The sale would reduce the company's holding in RSSPL by 26%, and the filing describes the transaction as a secondary sale of shares by Rashi Peripherals to Restar. The fund-raise and capital increase need shareholder approval, and a postal ballot notice will be submitted to the exchanges in due course.
The filing does not state the sale price or consideration for the 26% stake, the date the agreement will be signed, or the timing and amount of any fund-raise under the ₹900 crore approval. The next dated step is the postal ballot notice, which has no date yet.
Filed with NSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.